Your search for dabigatran returned 36 results

Patients with heart valve replacements have greater rates of thromboembolic and bleeding complications after treatment with dabigatran vs. warfarin.

For patients taking dabigatran, the risk of gastrointestinal bleeding (GIB) is reduced with use of gastroprotective agents.

No differences seen in fracture risk in head-to-head comparisons of direct oral anticoagulants

Resuming any anticoagulant found safer than stopping the drugs in these cases

Non-vitamin K oral anticoagulants exhibit variable effects on coagulation assays, according to a new study.

For patients initiating oral anticoagulant therapy, the incidence of hospitalization for upper gastrointestinal bleeding is highest and lowest with rivaroxaban and apixaban, respectively.

Compared with warfarin, dabigatran and rivaroxaban linked to lower risk of adverse renal outcomes

Effective for dabigatran reversal among patients with uncontrolled bleeding, undergoing urgent surgery

Study of newer medications finds 16 percent receive too much or too little

The researchers found that the risk of developing an intraocular hemorrhage was reduced with dabigatran or rivaroxaban at 365 days (hazard ratio, 0.75; 95% confidence interval, 0.58 to 0.97; P=0.03) but not at 90 days (hazard ratio, 0.73; 95% confidence interval, 0.22 to 2.63; P=0.13).